Stock Alert on Biotechnology Industry - NASDAQ:CELG, NASDAQ:PPHM, NASDAQ:PDLI, NASDAQ:LXRX

Pompano Beach, FL -- (SBWIRE) -- 01/03/2013 -- Celgene Corporation (NASDAQ:CELG) reported an upsurge of 3.35% after opening at the price of $80.12 its closing price for the day was $81.10.

CELG’s total trading volume for the day was 4.01 million shares versus its average volume of 2.88 million shares. Company’s current market capitalization stands at $34.30 billion along with 422.99 million shares. Its earning per share is $3.60 while its beta value stands at 0.50 times.

Celgene Corporation (NASDAQ:CELG) declared that on January 7, 2013 at 11:00a.m. E.T. Company will present at the 31st Annual J.P. Morgan Healthcare Conference, which will be available and webcast live on company’s official website under the section of investor relations. During this conference company’s overview will be provided by the management of Celgene Corporation.

What CELG’s Charts Are Signaling for Traders? Find Out Here

Peregrine Pharmaceuticals (NASDAQ:PPHM) opened at the price of $1.40 whereas its previous closing price was recorded at $1.34. PPHMincreased1.52% and traded within the day range of $1.30 - $1.44 for the day, 52week range of the stock remained in between $0.39 - $5.50.

Peregrine Pharmaceuticals (NASDAQ:PPHM) is a biopharmaceutical company which involves in research and expansion of monoclonal antibodies to diagnosis and treatment of viral infections and cancer.

Company’s total market capitalization stands at $177.60 billion along with 132.54 million outstanding shares. Total volume of the stock was 3.80 million shares during last trade while its average volume is 4.45 million shares.

Should PPHM a Buy or Sell Now? Find Out Here

PDL BioPharma Inc. (NASDAQ:PDLI) reported the upsurge of 4.26% and closed at $7.34 with the total traded volume of 3.07 million shares, stock’s opening price was $7.25. The company has total of 139.93 million outstanding shares and its total market capitalization is $1.03 billion.

52-week price range of the stock remained $6.00 - $8.43, while during last trade its minimum price was $7.20 and it gained highest price of $7.37.

Can PDLI Show a Strong Recovery? Find out in This Research Report

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) percentage change advanced 7.69% to close at $2.38 with the total traded volume of 4.56 million shares more than average volume of 1.07 million shares.

Company’s lowest price during last trade was $2.26 while its highest price remained $2.40 for the day. LXRX’s total market capitalization is $1.22 billion along with 512.37 million shares outstanding. Its beta value stands at 1.754 points and its earning per shares remained $-0.27.

Where LXRX is Headed Exactly? Find out in This Trend Analysis Reports

About TopStockPlays
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.

Disclaimer
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.